Medtronic MiniMed, Inc. recalls InPen App
- Published
- 24 Dec 2025
- Units affected
- 8251
- Agency
- FDA
- Country
- United States
The hazard
When app is uninstalled and reinstalled, insulin pen software issue causes Choose Notification Style Screen to not show during setup so users can't choose to allow notifications to override phone settings when on mute/Do Not Disturb, and previously set up override permission is deleted, so audible and vibratory notifications not received, which may lead to delayed insulin therapy, hyperglycemia.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
InPen App, Model/CFN Number: MMT-8061 (Android Users)
- Brand / company
- Medtronic MiniMed, Inc.
- Codes / lots
- Software Versions: 7.5.0, 7.5.1, and 8.0.0. UDI-DI: 00763000974596
- Distribution
- US: IL, AZ, MN, NE, KS, TN, CA, FL, TX, WA, MO, NC, NY, WI, IN, ME, CT, RI, MD, PA, OK, KY, MA, DE, UT, ID, VA, MI, OH, LA, NJ, IA, MT, HI, AR, OR, SC, AL, CO, WY, VT, NV, GA, MS, SD, AK, WV, NH, ND, NM. OUS: Austria, Belgium, Chile, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, South Africa, Spain, Sweden, Switzerland, United Kingdom
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 24 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.